3 research outputs found

    Promotional Campaigns in the Era of Social Platforms

    Get PDF
    The rise of social media has facilitated the diffusion of information to more easily reach millions of users. While some users connect with friends and organically share information and opinions on social media, others have exploited these platforms to gain influence and profit through promotional campaigns and advertising. The existence of promotional campaigns contributes to the spread of misleading information, spam, and fake news. Thus, these campaigns affect the trustworthiness and reliability of social media and render it as a crowd advertising platform. This dissertation studies the existence of promotional campaigns in social media and explores different ways users and bots (i.e. automated accounts) engage in such campaigns. In this dissertation, we design a suite of detection, ranking, and mining techniques. We study user-generated reviews in online e-commerce sites, such as Google Play, to extract campaigns. We identify cooperating sets of bots and classify their interactions in social networks such as Twitter, and rank the bots based on the degree of their malevolence. Our study shows that modern online social interactions are largely modulated by promotional campaigns such as political campaigns, advertisement campaigns, and incentive-driven campaigns. We measure how these campaigns can potentially impact information consumption of millions of social media users

    EClinicalMedicine

    Get PDF
    BACKGROUND: While acute kidney injury (AKI) is a common complication in COVID-19, data on post-AKI kidney function recovery and the clinical factors associated with poor kidney function recovery is lacking. METHODS: A retrospective multi-centre observational cohort study comprising 12,891 hospitalized patients aged 18 years or older with a diagnosis of SARS-CoV-2 infection confirmed by polymerase chain reaction from 1 January 2020 to 10 September 2020, and with at least one serum creatinine value 1-365 days prior to admission. Mortality and serum creatinine values were obtained up to 10 September 2021. FINDINGS: Advanced age (HR 2.77, 95%CI 2.53-3.04, p < 0.0001), severe COVID-19 (HR 2.91, 95%CI 2.03-4.17, p < 0.0001), severe AKI (KDIGO stage 3: HR 4.22, 95%CI 3.55-5.00, p < 0.0001), and ischemic heart disease (HR 1.26, 95%CI 1.14-1.39, p < 0.0001) were associated with worse mortality outcomes. AKI severity (KDIGO stage 3: HR 0.41, 95%CI 0.37-0.46, p < 0.0001) was associated with worse kidney function recovery, whereas remdesivir use (HR 1.34, 95%CI 1.17-1.54, p < 0.0001) was associated with better kidney function recovery. In a subset of patients without chronic kidney disease, advanced age (HR 1.38, 95%CI 1.20-1.58, p < 0.0001), male sex (HR 1.67, 95%CI 1.45-1.93, p < 0.0001), severe AKI (KDIGO stage 3: HR 11.68, 95%CI 9.80-13.91, p < 0.0001), and hypertension (HR 1.22, 95%CI 1.10-1.36, p = 0.0002) were associated with post-AKI kidney function impairment. Furthermore, patients with COVID-19-associated AKI had significant and persistent elevations of baseline serum creatinine 125% or more at 180 days (RR 1.49, 95%CI 1.32-1.67) and 365 days (RR 1.54, 95%CI 1.21-1.96) compared to COVID-19 patients with no AKI. INTERPRETATION: COVID-19-associated AKI was associated with higher mortality, and severe COVID-19-associated AKI was associated with worse long-term post-AKI kidney function recovery. FUNDING: Authors are supported by various funders, with full details stated in the acknowledgement section
    corecore